AAAAAA
Results: 51-75/696
Citation: DETROL - ORAL-AGENT FOR REDUCING URINARY FREQUENCY, URGENCY, URGE INCONTINENCE, Formulary, 33(6), 1998, pp. 496-496
Citation: AZOPT - TOPICAL CARBONIC-ANHYDRASE INHIBITOR FOR LOWERING INTRAOCULAR-PRESSURE, Formulary, 33(6), 1998, pp. 496-496
Citation: AMOXIL - USE WITH LANSOPRAZOLE, CLARITHROMYCIN FOR DUODENAL-ULCERS DUE TO HELICOBACTER-PYLORI, Formulary, 33(6), 1998, pp. 505-506
Citation: SUCRAID - ENZYME REPLACEMENT THERAPY FOR CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY, Formulary, 33(6), 1998, pp. 505-505
Citation: VIAGRA - ORAL-THERAPY FOR THE TREATMENT OF ERECTILE DYSFUNCTION, Formulary, 33(6), 1998, pp. 505-505
Citation: LOVENOX - USE WITH ASPIRIN TO PREVENT UNSTABLE ANGINA, NON-Q-WAVE MI COMPLICATIONS, Formulary, 33(6), 1998, pp. 506-506
Citation: TABLET FORMULATION APPROVED TO TREAT PRIMARY NOCTURNAL ENURESIS, Formulary, 33(6), 1998, pp. 506-506
Citation: MAXIPIME - USE WITH METRONIDAZOLE TO TREAT INTRAABDOMINAL INFECTIONS, Formulary, 33(6), 1998, pp. 506
Citation: PRAVACHOL - REDUCTION OF CV EVENTS IN PATIENTS WITH NORMAL CHOLESTEROL - TRIGLYCERIDE LOWERING, Formulary, 33(6), 1998, pp. 511-511
Citation: ZOCOR - REDUCTION OF THE RISK OF FIRST STROKE OR TRANSIENT ISCHEMIC ATTACK, Formulary, 33(6), 1998, pp. 511-511
Citation: PROSCAR - REDUCTION OF THE RISK OF ACUTE URINARY RETENTION, SURGERY IN BPH PATIENTS, Formulary, 33(6), 1998, pp. 511-511
Citation: PREVACID - SHORT-TERM TREATMENT OF GERD, Formulary, 33(6), 1998, pp. 511-511
Citation: TAMOXIFEN GUIDELINES FOR BREAST-CANCER PREVENTION PREMATURE, RESEARCHER SAYS, Formulary, 33(6), 1998, pp. 512-512
Citation: DOPAMINE AGONISTS TAKE ON EXPANDED ROLE IN REVISED PARKINSONS ALGORITHM, Formulary, 33(6), 1998, pp. 515
Citation: PRESCRIPTION COST EMERGES AS TOP DRIVER OF PATIENT SATISFACTION WITH PHARMACY BENEFITS, Formulary, 33(6), 1998, pp. 515-515
Citation: ZAFIRLUKAST SHOWS PROMISE AS ADJUNCT TO CORTICOSTEROIDS, Formulary, 33(6), 1998, pp. 518-518
Authors:
REDDY P
LEE N
Citation: P. Reddy et N. Lee, FOCUS ON NARATRIPTAN - AN ORAL 5-HT1 RECEPTOR AGONIST FOR ACUTE TREATMENT OF MIGRAINE, Formulary, 33(6), 1998, pp. 521
Authors:
JAHANGIR A
STANTON MS
HAMMILL SC
SHEN WK
Citation: A. Jahangir et al., CLASS-I AND CLASS-III ANTIARRHYTHMIC DRUGS - PRACTICAL CONSIDERATIONSFOR SAFE, EFFECTIVE USE, Formulary, 33(6), 1998, pp. 534
Authors:
SPRAGUE K
CUNHA BA
Citation: K. Sprague et Ba. Cunha, FACTORS IN THE DEVELOPMENT AND MAINTENANCE OF A RATIONAL ANTIBIOTIC FORMULARY PART 1, Formulary, 33(6), 1998, pp. 558
Authors:
BASSKIN L
Citation: L. Basskin, A PHARMACOECONOMIC ANALYSIS OF COUMADIN VERSUS GENERIC WARFARIN, Formulary, 33(6), 1998, pp. 573
Citation: 10TH ANNUAL NATIONAL MANAGED HEALTH-CARE CONGRESS - BENEFITS OF A PHARMACIST-RUN HTN CLINIC, GENERIC WARFARIN SUBSTITUTION FEATURED, Formulary, 33(6), 1998, pp. 589-591
Citation: ADVICE ON HEPARIN USE IN FLUSH SOLUTIONS FOR VASCULAR CATHETERS, Formulary, 33(6), 1998, pp. 592
Citation: GUIDELINES CREATED FOR ICU SEDATIVE USE, Formulary, 33(6), 1998, pp. 592-592
Citation: COST-EFFECTIVENESS OF ADMINISTERING IV PUSH ANTIBIOTICS, Formulary, 33(6), 1998, pp. 595-595
Authors:
WECHSLER J
Citation: J. Wechsler, PATIENT RIGHTS BILL CALLS FOR FORMULARY MANDATES, BUT MORE MODEST PROPOSALS ABOUND, Formulary, 33(6), 1998, pp. 598